Home › UniQure Deal Confirms Red-Hot Interest In Advanced Therapies
 

Keywords :   


UniQure Deal Confirms Red-Hot Interest In Advanced Therapies

2015-04-08 03:15:03| Trucking - Topix.net

If there is any sign that pharma is beating the bushes to flush out promising advanced therapies, it is that Bristol-Myers For a near-term outlay of nearly $100m, Bristol-Myers gets the heart failure candidate AAV-S100A1 and three other targets. Along with Bluebird Bio , Celladon and Voyager Therapeutics, UniQure shows that gene therapy has begun a modest but noteworthy renaissance.

Tags: advanced interest deal confirms

Category:Transportation and Logistics

Latest from this category

All news
30.09Eastern North Pacific Tropical Weather Outlook
30.09Atlantic Tropical Weather Outlook
30.09Eastern North Pacific Tropical Weather Outlook
30.09Tropical Depression Joyce Forecast Advisory Number 11
30.09Tropical Storm Isaac Graphics
30.09Tropical Storm Isaac Forecast Discussion Number 17
30.09Tropical Depression Twelve Forecast Discussion Number 2
30.09Summary for Tropical Storm Isaac (AT5/AL102024)
Transportation and Logistics »
30.09UK economy grew less than thought in spring
30.09House price growth at near two-year high
30.09Traditional steelmaking ends in Port Talbot
30.09Eastern North Pacific Tropical Weather Outlook
30.09Atlantic Tropical Weather Outlook
30.09Eastern North Pacific Tropical Weather Outlook
30.09California governor blocks landmark AI safety bill
30.09Tropical Depression Joyce Forecast Advisory Number 11
More »